Sarah Ketterer - Causeway Capital Management
Holding/activity history for Takeda Pharmaceutical Co. Ltd (TAK)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | 0 | 0.00 | Sell 100.00% | 0.16 | SEC | ||
| 2024 Q4 | 522,030 | 0.16 | Reduce 59.25% | 0.27 | $13.24 | $6,911,684 | SEC |
| 2024 Q3 | 1,281,192 | 0.45 | Reduce 5.39% | 0.03 | $14.22 | $18,218,553 | SEC |
| 2024 Q2 | 1,354,164 | 0.48 | Reduce 6.28% | 0.03 | $12.94 | $17,522,888 | SEC |
| 2024 Q1 | 1,444,908 | 0.52 | Add 7.38% | 0.04 | $13.89 | $20,069,770 | SEC |
| 2023 Q4 | 1,345,645 | 0.49 | Add 8.14% | 0.04 | $14.27 | $19,202,354 | SEC |
| 2023 Q3 | 1,244,309 | 0.51 | Add 11.04% | 0.05 | $15.47 | $19,249,467 | SEC |
| 2023 Q2 | 1,120,584 | 0.46 | Reduce 0.78% | <0.01 | $15.71 | $17,604,370 | SEC |
| 2023 Q1 | 1,129,366 | 0.45 | Reduce 15.09% | 0.09 | $16.48 | $18,611,952 | SEC |
| 2022 Q4 | 1,330,042 | 0.60 | Reduce 7.04% | 0.04 | $15.60 | $20,748,648 | SEC |
| 2022 Q3 | 1,430,705 | 0.52 | Reduce 5.05% | 0.03 | $12.97 | $18,556,000 | SEC |
| 2022 Q2 | 1,506,823 | 0.53 | Reduce 5.89% | 0.03 | $14.04 | $21,156,000 | SEC |
| 2022 Q1 | 1,601,046 | 0.55 | Add 6.09% | 0.03 | $14.32 | $22,927,000 | SEC |
| 2021 Q4 | 1,509,149 | 0.45 | Reduce 20.86% | 0.15 | $13.63 | $20,570,000 | SEC |
| 2021 Q3 | 1,906,998 | 0.70 | Reduce 6.12% | 0.04 | $16.38 | $31,237,000 | SEC |
| 2021 Q2 | 2,031,264 | 0.70 | Add 21.38% | 0.12 | $16.83 | $34,186,000 | SEC |
| 2021 Q1 | 1,673,455 | 0.61 | Add 8.37% | 0.05 | $18.26 | $30,557,000 | SEC |
| 2020 Q4 | 1,544,171 | 0.54 | Add 4.44% | 0.02 | $18.20 | $28,104,000 | SEC |
| 2020 Q3 | 1,478,524 | 0.50 | Reduce 4.02% | 0.02 | $17.84 | $26,377,000 | SEC |
| 2020 Q2 | 1,540,379 | 0.50 | Reduce 29.12% | 0.15 | $17.93 | $27,619,000 | SEC |
| 2020 Q1 | 2,173,365 | 0.53 | Reduce 13.15% | 0.07 | $15.18 | $32,992,000 | SEC |
| 2019 Q4 | 2,502,296 | 0.53 | Reduce 1.04% | <0.01 | $19.73 | $49,370,000 | SEC |
| 2019 Q3 | 2,528,500 | 0.52 | Reduce 0.76% | <0.01 | $17.20 | $43,490,000 | SEC |
| 2019 Q2 | 2,547,740 | 0.50 | Add 6.67% | 0.03 | $17.70 | $45,095,000 | SEC |
| 2019 Q1 | 2,388,353 | 0.49 | Add 8.35% | 0.04 | $20.37 | $48,651,000 | SEC |
| 2018 Q4 | 2,204,384 | 0.45 | Buy | 0.45 | $16.82 | $37,078,000 | SEC |